Combined effects of Lapatinib and Cisplatin on colony formation of head and neck squamous cell carcinoma

Authors :: Schrader, C
Boehm, A
Mozet, C
Dietz, A
Bertolini, J
Reiche, A
Wichmann, G
Source :: 83. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf-und Hals-Chirurgie; 20120516-20120520; Mainz; DOC12hnod301 /20120404/
Publication Year :: 2012
Publisher :: German Medical Science GMS Publishing House, 2012.
Abstract: Introduction: Lapatinib (LAP) targets tyrosine-kinases of EGFR/HER2-receptors and hence is under investigation regarding its value within multimodal therapy concepts of advanced head and neck squamous cell carcinoma (HNSCC). Methods: The potential of LAP alone and combined with cisplatin (CIS)[for full text, please go to the a.m. URL]<br />83. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf- und Hals-Chirurgie

Subjects :: ddc: 610
digestive, oral, and skin physiology
610 Medical sciences
Medicine
skin and connective tissue diseases

Language :: English
Database :: OpenAIRE
Journal :: 83. Jahresversammlung der Deutschen Gesellschaft für Hals-Nasen-Ohren-Heilkunde, Kopf-und Hals-Chirurgie; 20120516-20120520; Mainz; DOC12hnod301 /20120404/
Accession number :: edsair.doi.dedup.....4c22696244bef6fc277231f6de8d2894
Full Text :: https://doi.org/10.3205/12hnod301

Full Text Access

Tools